FORMULASI DAN EVALUASI SEDIAAN TABLET ASAM MEFENAMAT MENGGUNAKAN EKSIPIEN CROSCARMELLOSE SODIUM SEBAGAI DISINTEGRAN DENGAN METODE GRANULASI BASAH

Jafar Garnadi

Abstract


Mefenamic acid is a class of NSAIDs (Non-Steroid Antiinflammatory) which belongs to BCS group (Biopharmaceutical Classification System) class II that is low solubility with high penetration membrane. So it is necessary to increase the solubility to get absorption that can penetrate the maximum therapeutic zone of reagent. This study aims to determine the effect of the concentration of disintegran Croscarmellose sodium with a concentration of 1% - 5% on the physical quality and dissolution rate because it has a working mechanism of water absorption (water wicking) and swelling rapidly. Raw material collection, manufacture of mefenamic acid tablets (the wet granulation method is used because it can improve the flow rate and the compressibility of the mefenamic acid), evaluation of mefenamic acid granules, evaluation of mefenamic acid tablets, data analysis using one way ANOVA. Characterization of physical quality of granules moisture content, flow rate, fixed angle according to requirements. Characterization of quality tablet hardness, friability, frixibility, weight, uniformity size, disintegration time, and dissolution according to requirements.. Statistical analysis, indicating that there are significant differences in hardness, weight, uniformity of size, crushed time, rate and dissolution. From the results of this study can be concluded that the formula with a concentration of Croscarmellose Sodium 5% gives the best results.

 

Keywords: Mefenamic acid, Croscarmellose sodium, Wet granulation, Physical quality, Dissolution rate..


Full Text:

PDF (Indonesian)

References


Abdou, H.M., 1995, Dissolution, in Remington: The Science and Practice of Pharmacy, 19th ed., 729, Mack Publishing Co., Pennsylvania.

Agoes, G. 2006. Pengembangan Sediaan Pangan untuk Farmasi. Bandung: Institut Teknologi Bandung. Hal: 191-195.

Anief, M. 2008. Ilmu Meracik Obat Teori dan Praktek. Yogyakarta: Gadjah Mada University Press. Hal: 210, 211, 214.

Ansel, H.C., 1989, Introduction to Pharmaceutical Dosage Form, Terjemahan: Farida Ibrahim, Pengantar Bentuk Sediaan, Edisi keempat, Penerbit UI Press, p. 261-272.

Ansel, H. C. 2005. Pengantar Bentuk Sediaan Farmasi Edisi ke IV. Jakarta: UI Press. Hal: 244, 245, 247, 252, 255, 264.

Ansel, H.C., 1984, Introduction to Pharmaceutical Dosage Form, Terjemahan: Farida Ibrahim, Pengantar Bentuk Sediaan, Edisi Keempat, Penerbit UI Press, p.254-272. 378.

Balasubramaniam, J. & Bee, T., 2009, Influence of Superdisintegrants on the Rate of Drug Dissolution from Oral Solid Dosage Form, Pharmaceutical Technology, April.

Banker. G.S., Anderson, N.R., 1986, Tablet dalam : Lachman, L., Lieberman, H.A., Kanig J.L., (editor), Penerjemah; Siti Suyatmi, J. Kawira, Iis Aisyah, Teori dan Praktek Farmasi Industri, vol.2, Edisi III, UI Press, Hal: 55, 58, 662, 685, 690.

Cartensen, J.T., Chan, P.C., 1977, Flow rates and Repose angel of Wet Processes Granulation, J.Pharm. Sci, vol 66., p.1235

Departemen Kesehatan Edisi III, 1979, Departemen Kesehatan RI, Jakarta

Departemen Kesehatan Edisi IV, 1995, Departemen Kesehatan RI, Jakarta

First annual preformulate survey, 2003, PFormulate A Tablet, @PFORMULATE.com, in: www.google.com.

FDA, Center for Drug Evaluation and Research. 1997. Guidance for Industry, Dissolution Testing of Immediate Release Solid Oral Dosage Form. Rockville, MD: CDER.

Fonner, D.E., N.R. Andenson, G. S. Banker., 1990. Granulation and Tablet Characteristics, in : Lieberman, H. A., L. Lachman, (eds.), Pharmaceutical Dosage Forms : Tablets, vol. 2, New York: Marcel Dekker Inc., pp. 245-254.

Ganiswara, G.S., Ed, 1995, Farmakologi dan Terapi, Edisi Keempat, Bag. Farmakologi Fakultas Kedokteran Univ. Indonesia Jakarta, hal: 207-210, 217.

Hadimoelyo.S., 1990, Pengaruh Bahan Pengisi Terhadap Waktu Hancur dan Profil Disolusi Kapsul Asam Mefenamat, dalam : Majalah Farmasi Airlangga vol.1, No.1, ham 40-45

Khan, K.A., 1975, The Concept of Dissolution Efficiency, J.Pharm. Sci, vol.27, p.48-49.

Kumar , G.P. dan Nirmala, R., 2012. Fundamental Aspect of Superdisintegrants: A Concise Review. JGPT, 4:1-12.

Lachman, L, Lieberman, H. A. Kanig. J. L. 1994. Teori dan Praktek Farmasi Industri (terjemahan) oleh Siti Suyatmi Edisi I dan II. Jakarta: UI Press. Hal: 645, 646, 647, 648, 654, 657, 658, 659, 697, 698, 699, 702, 703.

Lieberman, H.A., Lachman, L., 1994, Terjemahan: Teori dan Praktek Farmasi Industri, edisi III, Indonesia University Press, 644-645, 680-999

Martin, A., Swabick, J., Cammarata, A., (editor), 1993 penerjemah: Yoshita, Farmasi Fisik, jilid 2, edisi 3, Indonesia University Press, hal: 939-967.

Reynold, J.E.F., 1982, Martindle The Extra Pharmacopoeia, 28th ed, The Pharmaeutical press London, 262-263, 1440-1441, 1474-1476.

Rowe, Sheskey, dan Quinn (Eds.). 2009. Handbook of Pharmaceutical Excipients Sixth Edition. Ed. Pharmaceutical Press, London.

Rowe RC, Sheskey PJ, Quinn ME, editors. Handbook of Pharmaceutical Excipients, 6. Ed. London: AphA (PhP) Pharmaceutical Press; 2009. 888p.

Shargel, L., Yu Andrew, B.C., 1988, Penerjemah : Fasich, Siti Syamsiah, Biofarmasetika dan Farmakokinetika Terapan, edisi 2, Airlangga University Press, hal 89-98.

Singh, J. Dan Singh, R., 2009. Optimization and Formulation of Orodispersible Tablets of Meloxicam. Trop J Pharm, 8: 153-159.

Siregar, C., dan Wikarsa, S., 2010, Teknologi Farmasi Sediaan Tablet: Dasar-Dasar Praktek, Penerbit Buku Kedokteran EGC, Jakarta.

Sulaiman, T. N. S. 2007. Teknologi dan Formulasi Sediaan Tablet. Yogyakarta: Laboratorium Teknologi Farmasi UGM. Hal: 102, 149, 150, 199, 200, 203, 206.

The United States Pharmacopoeia 25nded, 2002, United States Pharmacopoeia Convection. Inc.

The United States Pharmacopoeia 38thed, 2015, United States Pharmacopoeia Convection. Inc.

Voight, R., 1994. Buku Pelajaran Teknologi Farmasi (terjemahan), Gadjah Mada University Press, Yogyakarta: pp. 157-158.

Yalkowsky, S.H., 1981, Tecniques of Solubilization of Drugs, 12-13; 135-157, Marcel Dekker Inc., New York.




DOI: http://dx.doi.org/10.36465/jop.v2i1.470

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Journal of Pharmacopolium

p-ISSN: 2620-8563; e-ISSN: 2621-1521


Index:

RJI Main logo